Skip to main content

Want a detailed portfolio tracker?

Arcellx (ACLX) P/E (2022 - 2026)

Arcellx (ACLX) P/E from Mar 31, 2022 to Apr 28, 2026. The TTM Arcellx (ACLX) P/E is -28.40. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Arcellx (ACLX)

YearP/EChange
2026-28.40+76.49%
2025-16.09-58.28%
2024-38.57+177.36%
2023-13.90+59.33%
2022-8.73N/A

Comparison Arcellx (ACLX) P/E with competitors

Arcellx (ACLX) P/E is -28.40.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.26%
FGENFibroGen Inc0.24-100.85%
CHRSCoherus Biosciences Inc0.85-102.99%
FBIOFortress Biotech Inc0.95-103.34%
ORMPOramed Pharmaceuticals Inc1.50-105.29%
AGENAgenus Inc3.01-110.60%
INVAInnoviva Inc3.15-111.11%
VXRTVaxart Inc3.55-112.50%
CRMDCorMedix Inc3.63-112.78%
CVACCureVac N.V.4.45-115.66%
GLPGGalapagos NV4.86-117.11%
SRPTSarepta Therapeutics Inc4.88-117.19%
ABEOAbeona Therapeutics Inc5.39-118.97%
ABUSArbutus Biopharma Corp5.60-119.71%
ZVRAZevra Therapeutics Inc5.89-120.73%
SPROSpero Therapeutics Inc6.23-121.93%
CGENCompugen Ltd6.31-122.23%
RIGLRigel Pharmaceuticals6.87-124.20%
SLXNSilexion Therapeutics Corp7.30-125.69%
OMEROmeros Corporation9.26-132.61%
AUPHAurinia Pharmaceuticals Inc9.58-133.75%
PLXProtalix BioTherapeutics Inc10.89-138.35%
TBPHTheravance Biopharma Inc12.26-143.18%
ADMAAdma Biologics Inc12.42-143.73%
HRMYHarmony Biosciences Holdings Inc13.82-148.67%
SABSSAB Biotherapeutics Inc14.14-149.78%
NAGENiagen Bioscience Inc14.82-152.18%
INCYIncyte Corp15.82-155.72%
REGNRegeneron Pharmaceuticals Inc15.86-155.84%
PBYIPuma Biotechnology Inc17.32-160.98%
CPRXCatalyst Pharmaceuticals Inc17.44-161.41%
EXELExelixis Inc17.54-161.76%
TGTXTG Therapeutics Inc18.97-166.79%
MDXGMimedx Group Inc20.55-172.38%
XOMAXOMA Royalty Corp22.87-180.56%
ARGXArgen X SE24.30-185.57%
CTMXCytomX Therapeutics Inc24.82-187.41%
XOMAOXOMA Royalty Corp25.34-189.26%
HALOHalozyme Therapeutics Inc25.62-190.24%
XOMAPXOMA Royalty Corp25.67-190.40%
VRTXVertex Pharmaceuticals Inc27.99-198.59%
RPRXRoyalty Pharma plc - Class A28.69-201.03%
SLNOSoleno Therapeutics Inc29.02-202.18%
ASNDAscendis Pharma A/S30.09-205.95%
LGNDLigand Pharmaceuticals Inc - Class B37.91-233.51%
APLSApellis Pharmaceuticals Inc39.02-237.42%
BMRNBiomarin Pharmaceutical Inc42.21-248.66%
KRYSKrystal Biotech Inc45.34-259.68%
ONCBeiGene Ltd69.54-344.90%
PHARPharming Group N.V.75.03-364.21%
TECHBio-Techne Corp101.96-459.06%
VCELVericel Corp109.92-487.11%
ALNYAlnylam Pharmaceuticals Inc117.96-515.43%
GMABGenmab140.29-594.06%
TLXTelix Pharmaceuticals Ltd162.15-671.05%
CORTCorcept Therapeutics Inc212.86-849.61%